Treatment Outcomes in Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer Patients with and without Progression after Completion of Reimbursed Cyclin-dependent Kinase 4/6 Inhibitors in Taiwan: A Single-institution Experience.
Saved in:
| Title: | Treatment Outcomes in Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer Patients with and without Progression after Completion of Reimbursed Cyclin-dependent Kinase 4/6 Inhibitors in Taiwan: A Single-institution Experience. |
|---|---|
| Authors: | Hsu, Yi-Hsuan1 (AUTHOR), Yang, Po-Shen2 (AUTHOR), Chang, Yuan-Ching2 (AUTHOR), Lam, Hung-Bun2 (AUTHOR), Lee, Fang2 (AUTHOR), Hung, Chia-Yen1 (AUTHOR), Lin, Johnson1 (AUTHOR), Su, Nei-Wen1 (AUTHOR), Chiang, Yi-Hao1 (AUTHOR), Lin, Huan-Chao1 (AUTHOR), Ko, Wen-Ching2 (AUTHOR), Tsai, Chung-Hsin2 (AUTHOR), Su, Ying-Wen1 (AUTHOR) cowayneish25@gmail.com |
| Source: | Journal of Cancer Research & Practice. Jan-Mar2026, Vol. 13 Issue 1, p9-17. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23113006 |
|---|---|
| DOI: | 10.4103/ejcrp.eJCRP-D-25-00018 |
